National Institute of Technology Rourkela

राष्ट्रीय प्रौद्योगिकी संस्थान राउरकेला

ଜାତୀୟ ପ୍ରଯୁକ୍ତି ପ୍ରତିଷ୍ଠାନ ରାଉରକେଲା

An Institute of National Importance

All Publications

Sujit Kumar Bhutia

Professor
sujitb@nitrkl.ac.in

S. Dash, S. Pasayat, S. Bhakat, S. Roy, R. Dinda, E. T. Tiekink, S. Mukhopadhyay, S. K. Bhutia, M. Hardikar, B. Joshi, Y. P. Patil, and M. Nethaji,"Highly stable hexacoordinated nonoxidovanadium(IV) complexes of sterically constrained ligands: Syntheses, structure, and study of antiproliferative and insulin mimetic activity", Inorganic Chemistry, vol.52, no.24, pp.14096-14107, ACS, September 2013, 10.1021/ic401866x       Article
S. K. Bhutia, S. K. Das, B. Azab, M. E. Menezes, P. Dent, X. Y. Wang, D. Sarkar, and P. B. Fisher,"Targeting breast cancer-initiating/stem cells with melanoma differentiation-associated gene-7/interleukin-24", International Journal of Cancer, vol.133, no.11, pp.2726-2736, Wiley, July 2013, 10.1002/ijc.28289       Article
S. K. Das, S. K. Bhutia, B. Azab, T. P. Kegelman, L. Peachy, P. K. Santhekadur, S. Dasgupta, R. Dash, P. Dent, S. Grant, L. Emdad, M. Pellecchia, D. Sarkar, and P. B. Fisher,"MDA-9/Syntenin and IGFBP-2 promote angiogenesis in human melanoma", Cancer Research, vol.73, no.2, pp.844-854, AACR, January 2013, 10.1158/0008-5472.CAN-12-1681       Article
S. Dash, S. Pasayat, S. Bhakat, S. Roy, R. Dinda, E., S. Mukhopadhyay, S. K. Bhutia, M. Hardikar, B. Joshi, Y. Patil, and M. Nethaji,"Highly stable hexacoordinated nonoxidovanadium(IV) complexes of sterically constrained ligands: Syntheses, structure, and study of antiproliferative and insulin mimetic activity", Inorganic Chemistry, vol.52, no.24, pp.14096-14107, American Chemical Society 2013, 10.1021/ic401866x       Article
N. Sinha, S. Mukhopadhyay, D. N. Das, P. K. Panda, and S. K. Bhutia,"Relevance of cancer initiating/stem cells in carcinogenesis and therapy resistance in oral cancer", Oral Oncology, vol.49, no.9, pp.854–862, Elsevier, September 2013, 10.1016/j.oraloncology.2013.06.010       Article
S. K. Bhutia, S. Das, T. Kegelman, B. Azab, R. Dash, . Zhao, . Xiang, F. Rizzi, S. Bettuzzi, S. G. Lee, P. Dent, S. Grant, D. T. Curiel, D. Sarkar, and P. B. Fisher,"mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer", Journal of Cellular Physiology, vol.227, no.5, pp.1805-1813, Wiley, January 2012, 10.1002/jcp.22904       Article
B. Azab, R. Dash, S. K. Das, S. K. Bhutia, X. N. Shen, B. A. Quinn, S. Sarkar, X. Y. Wang, M. Hedvat, I. P. Dmitriev, D. T. Curiel, S. Grant, P. Dent, J. C. Reed, M. Pellecchia, D. Sarkar, and P. B. Fisher,"Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells", Journal of Cellular Physiology, vol.227, no.5, pp.2145-2153, Wiley, January 2012, 10.1002/jcp.22947       Article
P. Venkatesan, S. K. Bhutia, A. Singh, S. Das, R. Dash, K. Chaudhury, D. Sarkar, P. Fisher, and M. Mandal,"AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells", Life Sciences, vol.91, no.15-16, pp.789–799, Elsevier, October 2012, 10.1016/j.lfs.2012.08.024       Article
S. Das, S. K. Bhutia, U. Sokhi, B. Azab, Z. Z. Su, H. Boukerche, T. Anwar, E. Moen, D. Chatterjee, M. Pellecchia, D. Sarkar, and P. Fisher,"Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma", Cancer Res, vol.72, no.23, pp.6217–6226, NIH Public Access, December 2012, 10.1158/0008-5472.CAN-12-0402       Article
S. Kar, M. Deb, D. Sengupta, A. Shilpi, S. K. Bhutia, and S. K. Patra,"Intricacies of hedgehog signaling pathways: A perspective in tumorigenesis", Experimental Cell Research, vol.318, no.16, pp.1959–1972, Elsevier, May 2012, 10.1016/j.yexcr.2012.05.015       Article